Core Viewpoint - GSK plans to invest $30 billion in research and development and supply chain infrastructure in the United States over the next five years [1] Investment Plans - The investment will focus on enhancing research and development capabilities [1] - The funds will also be allocated to improving supply chain infrastructure [1] Timeline - The investment is set to take place over the next five years [1]